- Q1 2024 Kura Oncology Inc Earnings Call TranscriptMay 02, 2024€18.75 (+1.13%)Earnings
- Q4 2023 Kura Oncology Inc Earnings Call TranscriptFeb 27, 2024€19 (+2.15%)Earnings
- Kura Oncology Inc To Discuss Preliminary Combo Data Call TranscriptJan 30, 2024
- Q3 2023 Kura Oncology Inc Earnings Call TranscriptNov 02, 2023€7.5 (-5.66%)Earnings
- Q2 2023 Kura Oncology Inc Earnings Call TranscriptAug 03, 2023€9.35 (+0.54%)Earnings
- Kura Oncology Inc Investor Day TranscriptJun 12, 2023
- Kura Oncology Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 Kura Oncology Inc Earnings Call TranscriptMay 10, 2023€10.4 (+2.97%)Earnings
- Kura Oncology Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 25, 2023
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Kura Oncology Inc Earnings Call TranscriptFeb 23, 2023€11.2 (+1.82%)Earnings
- Kura Oncology Inc ASH Investor Event Call TranscriptDec 10, 2022
- Kura Oncology Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kura Oncology Inc Earnings Call TranscriptNov 03, 2022€15.8 (-1.25%)Earnings
- Q2 2022 Kura Oncology Inc Earnings Call TranscriptAug 03, 2022€14.6 (+1.39%)Earnings
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Kura Oncology Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) TranscriptJun 02, 2022
- Q1 2022 Kura Oncology Inc Earnings Call TranscriptMay 04, 2022€14.1 (-0.70%)Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2022€12.2 (-3.17%)Earnings
- Kura Oncology Inc at Clinical Update Call TranscriptNov 24, 2021
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 Kura Oncology Inc Earnings Call TranscriptNov 04, 2021€15.7 (+6.80%)Earnings
- Kura Oncology Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Q2 2021 Kura Oncology Inc Earnings Call TranscriptAug 05, 2021€14.8 (-2.63%)Earnings
- Q1 2021 Kura Oncology Inc Earnings Call TranscriptMay 06, 2021€21.2Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Kura Oncology Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2021€27.2 (+0.74%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Kura Oncology Inc ASH Virtual Investor Event TranscriptDec 05, 2020
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 Kura Oncology Inc Earnings Call TranscriptNov 05, 2020€28.2 (-2.08%)Earnings
- Q2 2020 Kura Oncology Inc Earnings Call TranscriptAug 06, 2020€14.7 (+2.08%)Earnings
- Kura Oncology Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Kura Oncology Inc Earnings Call TranscriptMay 04, 2020€13.4 (-6.29%)Earnings
- Q4 2019 Kura Oncology Inc Earnings Call TranscriptFeb 25, 2020€11.5 (+1.77%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Kura Oncology Inc Earnings Call TranscriptNov 05, 2019€13.6 (+0.74%)Earnings
- Kura Oncology Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Kura Oncology Inc Earnings Call TranscriptAug 01, 2019€17.11 (+0.29%)Earnings
- Kura Oncology Inc EHA Data Review Conference Call TranscriptJun 14, 2019
- Kura Oncology Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kura Oncology Inc Earnings Call TranscriptMay 07, 2019€13.96 (+3.03%)Earnings
- Q4 2018 Kura Oncology Inc Earnings Call TranscriptMar 05, 2019€13.13 (-1.50%)Earnings
Kura Oncology Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hey, everybody. It is Alethia Young here. I cover large-cap, small/mid-cap biotech at Cantor. I'm very happy to have Kura Oncology here with me, Dr. Troy Wilson, who is the President and CEO. So we will be doing a fireside chat for the next 30 minutes. And what I want to first do is let Troy frame the Kura story, and then we will dig into detail on the key products. So with that, Troy, please go ahead.
Sure. Alethia, thank you to you and the Cantor team for the opportunity to participate in the fireside chat and in the conference. So at Kura Oncology, we are now advancing three pillars, all in the area of precision medicine and oncology. The first is our menin-MLL inhibitor for the treatment of genetically defined subtypes of acute leukemia. That program is in a Phase 1b study.
The next program is tipifarnib, which is an inhibitor of the farnesyl transferase enzyme. That program is in a registration directed study in HRAS mutant head and neck cancer. And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)